EP0191238B1 - Conducteur pour stimulateur cardiaque à sensibilité élevée - Google Patents

Conducteur pour stimulateur cardiaque à sensibilité élevée Download PDF

Info

Publication number
EP0191238B1
EP0191238B1 EP85309233A EP85309233A EP0191238B1 EP 0191238 B1 EP0191238 B1 EP 0191238B1 EP 85309233 A EP85309233 A EP 85309233A EP 85309233 A EP85309233 A EP 85309233A EP 0191238 B1 EP0191238 B1 EP 0191238B1
Authority
EP
European Patent Office
Prior art keywords
electrodes
conducting
electrode
lead
pacemaker lead
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP85309233A
Other languages
German (de)
English (en)
Other versions
EP0191238A1 (fr
Inventor
James E. Sluetz
Benjamin D. Pless
Paul R. Spehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermedics Inc
Original Assignee
Intermedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermedics Inc filed Critical Intermedics Inc
Priority to AT85309233T priority Critical patent/ATE53502T1/de
Publication of EP0191238A1 publication Critical patent/EP0191238A1/fr
Application granted granted Critical
Publication of EP0191238B1 publication Critical patent/EP0191238B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A61N1/0565—Electrode heads

Definitions

  • the invention concerns a pacemaker lead with an electrode structure which allows electrical signals of the heart to be detected with greater sensitivity. More particularly, the invention relates to such a lead which provides two relatively closely spaced sensing electrodes at the tip portion of the lead for rejecting far field electrical signals and concentrating sensing at the distal tip of the lead.
  • pacemakers In a diseased heart the natural electrical system of the heart is disrupted so that the heart cannot sustain a normal pumping rhythm by itself. A pacemaker is therefore required to provide timed electrical stimulation signals to either or both of the atrium and ventricle of the heart. It is well-known that pacemakers may also sense natural electrical activity in the atrium or ventricle and automatically inhibit stimulation or pacing in response to appropriately timed natural electrical activity.
  • a pacemaker In operation, a pacemaker is typically implanted within the body in the chest cavity of the patient and an electrically conducting pacing lead is positioned within the body between the pacemaker and the heart, for example by passing the electrode along a vein to an interior region of the heart at which sensing and pacing will occur.
  • Typical pacemaking leads are constructed with one or more coils of conducting wire which are covered by an outer sheath of an insulating material, for example polyurethane, to form the body of the lead.
  • the lead has a proximal end with a connector which is plugged into the pacemaker and a distal electrode end which is affixed to heart tissue to stimulate the tissue and detect electrical cardiac signals.
  • the distal end of typical pacemaking leads includes an electrically conducting tip which is held against the cardiac tissue. If the lead is unipolar, this tip electrode defines the active part of a circuit between the heart and the pacemaker and the electrically conducting housing of the pacemaker provides the ground for this circuit.
  • the unipolar lead thus has a single coil of wire which connects the pacemaker at one end to the pacing and sensing tip electrode at the other.
  • unipolar pairing lead for attachment to the heart is disclosed in DE-A-3230081 in which the unipolar electrode is formed by one end of a conductive tube within which, but electrically insulated therefrom, is located a moveable screw-in tip for holding the lead in position.
  • the screw-in tip does not contribute to the stimulation since it is known that, upon damage to the cardiac tissue, an increase in the stimulus threshold arises at this point.
  • a bipolar pacing lead has the above-described tip electrode disposed at its distal end and an associated ring electrode disposed on the body of the lead, usually approximately 2 centimeters from the tip.
  • the bipolar lead body typically includes two coaxially disposed conducting coils which are insulated from one another. One of the coils is conductively connected to the tip electrode and the other of the coils is conductively connected to the ring electrode. Pacing and sensing of cardiac tissue is thus achieved between the active tip electrode and passive ring electrode.
  • Bipolar pacing leads with the above-described structure have been found adequate for sensing electrical activity of the ventricle and pacing the ventricle.
  • the pacing lead is disposed so that the tip electrode contacts the wall of the heart in the ventricle and senses electrical activity in a field defined between the tip and ring electrodes.
  • This electrode structure has been found adequate to detect electrical QRS signals (R-waves) which cause natural contraction of the ventricle. If the tip electrode of the pacing lead is placed against the right ventricle, such QRS signals have a sufficiently large amplitude to be relatively easily detected by circuitry in the remote implanted pacemaker.
  • the natural atrial signal or P-wave is so low in energy that it does not interfere with the detection of the relatively powerful QRS signal in the ventricle.
  • the amplifiers of the signal detection circuitry of the pacemaker may relatively easily detect QRS signals.
  • the present invention provides a pacemaker lead having a proximal end for conductively connecting with a cardiac pacemaker, a distal end with electrodes for conductively contacting cardiac tissue and conducting means for conductively connecting the electrodes of the distal end with the proximal end, characterised by:
  • An advantage of this structure is that it will allow P-wave signals to be detected in the atrium with enhanced sensitivity and that it will discriminate such atrial signals from R-waves of the ventricle.
  • a further advantage is that it detects P-wave signals in the near field but does not detect QRS signals in the far field of the lead.
  • the body implantable pacing lead of the invention includes a distal end portion which is disposed to contact cardiac tissue, for example tissue in the atrium of the heart.
  • cardiac tissue for example tissue in the atrium of the heart.
  • an electrically conducting tip electrode is disposed at the distal end of the lead and an associated inner electrode is disposed in insulated coaxial relation with the tip electrode to sense atrial P-waves with the tip electrode.
  • the distal end of the lead further includes an insulated corkscrew which affixes the electrodes in conductive contact with the cardiac tissue.
  • a second embodiment of the lead of the invention has a distal portion which includes split-tip electrodes that are disposed in closely spaced, insulated relation with one another to detect electrical signals of adjacent abutting cardiac tissue.
  • a third embodiment of the lead of the invention has an electrically conducting tip electrode disposed at its distal end for stimulating cardiac tissue and two sense electrodes embedded in insulated relation within and extending from the face of the tip electrode to contact cardiac tissue for sensing electrical signals.
  • a fourth embodiment of the lead of the invention has a tip electrode disposed at its distal end for pacing cardiac tissue and an associated electrically conducting tine assembly disposed in insulated relation to the tip electrode for affixing the electrode to cardiac tissue and operating with the electrode to detect cardiac signals.
  • a fifth embodiment of the invention has an electrically conducting tip electrode disposed at its distal end and an associated inner electrode coaxially disposed in insulated relation with the tip electrode.
  • the electrodes are conductively connected with the pacemaker by a lead body which includes conducting bifilar coils that are independently insulated and intermeshed to provide a lower profile for the lead body.
  • FIG. 1 illustrates a perspective view of a heart pacemaker 1 and an associated lead 3 which includes a proximal connector portion 5 that plugs into a mating connector of the pacemaker and a distal head portion 7 that may be passed along a vein to lodge within the interior of the heart.
  • the lead 3 contains electrically conducting wires which connect the proximal connector 5 and distal head portion 7 so that electrical signals can be transmitted from the pacemaker to stimulate the heart at the tip of the distal head portion 7.
  • the conductors also allow electrical signals occurring in the heart to be transmitted from the distal head portion to the pacemaker for detection by circuitry within the pacemaker.
  • the heart pacemaker 1 may include circuitry for sensing electrical activity of the heart and generating pacing signals as required by the heart.
  • FIG. 2 illustrates a perspective view in partial section of the distal head portion 7 of the lead 3.
  • the lead includes an outer sheath 9 which may be made of any suitable biocompatible insulating material, for example polyurethane or silicone rubber.
  • the lead includes an outer electrically conducting coil of wire 11 and an associated coaxially disposed inner electrically conducting coil 13 which are separated by an insulating sheath 15 which may be made of any suitable, biocompatible insulating material such as polyurethane or silicone rubber.
  • FIG. 3 illustrates a cross-sectional view of the distal head portion 7 of the lead 3 taken along a line 3-3.
  • Fig. 3 illustrates the outer flexible insulating sheath 9, conducting coils 11 and 13 and inner insulating sheath 15.
  • FIG. 4 illustrates a cross-sectional view of the distal head portion 7 of Fig. 2 taken along line 4-4.
  • the distal end of the lead includes a first electrically conducting tip electrode 17 and second electrically conducting inner electrode 19 with a wire portion 23 and a conducting ball tip 21.
  • the electrode 17 may be made of any suitable biocompatible metal, such as a platinum-iridium alloy, titanium, carbon, or a carbon coated porous sintered titanium.
  • the wire 23 of the inner electrode may be made of a conducting nickel-cobalt alloy such as is known in the art and the ball tip may be made of platinum, carbon, or any other known biocompatible conducting material.
  • the tip electrode 17 has a chamber 16 formed therein which contains a corkscrew affixation element or anchor 25 which is made of a coil of conducting wire 27 with a coating of insulating material 29, for example Parylene C manufactured by Union Carbide.
  • the wire of the anchor 25 may be made of a nickel-cobalt alloy or stainless steel.
  • the distal portion of the wire 23 of the inner electrode 19 is supported within the anchor 25 by a sleeve 31 which may be made of any suitably rigid material, for example titanium or stainless steel.
  • the assembly which includes the anchor 25, sleeve 31 and distal portion of the wire 23 is disposed within the chamber 16 of the tip electrode 17.
  • the anchor 25, sleeve 31 and distal portion of the wire 23 are potted within the chamber 16 by a suitable medical adhesive 33, for example a silicone rubber adhesive such as Medical Adhesive Type A made by Dow Corning.
  • the lead includes an outer conducting coil 11 and an associated coaxially disposed inner conductive coil 13 which run along the lead 3 and conductively connect the tip electrode 17 and inner electrode 19 with the proximal connector 5 of the lead.
  • the wire 23 of the inner electrode 19 is conductively connected with the outer coil 11 by an electrically conducting crimp connector 35 made of, for example titanium or stainless steel.
  • the crimp connector 35 is a sleeve into which the ends of the wires 11 and 23 are inserted. A tool is employed to crimp the connector 35 and thus hold the ends of the wires in conductive connection.
  • the inner coil 13 of the lead is disposed within a chamber 37 which is formed by the electrically conducting body of the tip electrode 17.
  • the inner coil 13 is held in conductive connection with the body of the tip electrode 17 by the interaction of crimp portions 39 and an inner stake 41 which may be made of a suitably rigid material, for example titanium or stainless steel.
  • the stake 41 is initially inserted into the end of the inner coil 13 and the coil is then inserted within the chamber 37 of the tip electrode 17. Thereafter, the body of the tip electrode 17 is crimped at the crimp portions 39 to compress the inner coil 13 against the stake 41 and thus hold the inner coil in firm conductive contact with the body of the tip electrode 17.
  • the outer and inner coils 11 and 13 are separated in insulated relation by the inner insulating sleeve 15 which also extends along the body of the tip electrode 17 to insulate the crimp connector 35 and wire 23 from the electrode 17. It should be further understood that the medical adhesive 33 within the chamber 16 holds the distal portion of the wire 23 in insulated relation with respect to the tip 17. Thus, the coils 11 and 13 respectively conductively connect the tip electrode 17 and its associated coaxial inner electrode 19 with the pacemaker 1.
  • a polyurethane adhesive is used to glue and seal the outer polyurethane sheath 9 and inner polyurethane sheath 15 to the shank of the electrode 17. If the sheaths are made of silicone rubber, a suitable silicone rubber adhesive such as Medical Adhesive Type A should be used.
  • the corkscrew anchor 25 is held within the chamber 16 of the tip electrode 17 by the interaction of crimp portions 32 with the rigid sleeve 31.
  • the wire 23 is passed through the sleeve 31 and the sleeve and wire are then inserted within the chamber 16.
  • the corkscrew anchor 25 is disposed around the sleeve 31 in coaxial relationship with the sleeve and the medical adhesive 33 is injected into the chamber 16 and is allowed to solidify to pot the elements within the chamber.
  • the body of the tip electrode 17 is crimped at the crimp portions 32 to hold the corkscrew anchor within the chamber 16 with approximately three turns of the corkscrew anchor extending outside the front face of the electrode 17.
  • the lead assembly of Figs. 1-5 is positioned in the atrium in a manner known to the art, so that the anchor abuts the wall of the atrium. Thereafter, the flexible lead 3 is twisted so that the projecting end of the insulated corkscrew anchor 25 turns into the cardiac tissue 43 of the atrium. The lead is turned until the end of the corkscrew anchor 25 is fully embedded within the atrium with the front face of the tip electrode 17 and the ball tip 21 of the inner electrode 19 held in conductive contact against the tissue 43.
  • the tip electrode 17 and associated inner electrode 19 may be utilized as bipolar electrical elements to stimulate the cardiac tissue 43.
  • the tip electrode 17 may be utilized as an active electrode with respect to the conducting body of the pacer 1 to stimulate the cardiac tissue 43 in the manner of a unipolar lead.
  • the tip electrode 17 and inner electrode 19 are employed as bipolar electrode sensing elements.
  • the electrode structure of Fig. 4 has been experimentally tested in canines to determine its sensitivity to atrial P-waves.
  • the sensitivity is defined as the ratio of the magnitude in volts of the detected P-wave and the magnitude in volts of the associated detected R-wave in the atrium.
  • This P-R ratio was compared with a P/R ratio of 1.21 which was measured by sensing between thetip 17 of the electrode and a remote ground plate which was employed to simulate unipolar sensing with respect to the conducting body of a pacer.
  • a P/R ratio of 2.29 was detected for sensing between the inner electrode 19 and the remote ground plate.
  • the lead of the invention substantially increases the signal to noise ratio of the detected atrial signal.
  • the circuitry of the pacemaker 1 therefore relatively easily detect P-waves in the atrium and ignore or disregard the corresponding relatively low amplitude R-waves.
  • This substantially enhanced sensitivity for atrial signals is advantageous, because it allows easy detection of atrial P-waves without requiring relatively sophisticated and complex circuitry for discriminating between P-waves and R-waves.
  • the structure of the lead of Figs. 1-5 thus enhances the sensitivity of the pacemaker to signals in the atrium.
  • the enhanced sensitivity of the electrode structure of Figs. 1-5 is achieved because the combination of the electrodes 17 and 19 results in shorting out the far field electrical activity of the ventricle.
  • the electrodes thus detect a strong signal only in the immediate vicinity of the tissue which is contacted.
  • the electrodes 17 and 19 are therefore sensitive to P-waves which occur in the atrium and which pass directly over the electrodes and are much less sensitive to far field R-waves which occur in the ventricle.
  • typical pacing leads do not achieve this result, at least because the ring electrode in such leads is held away from the cardiac tissue which is contacted by the tip electrode.
  • the tip electrode 17 is about 2 mm in diameter and is therefore less than 1 mm from the inner electrode 19. It is believed that the direct contact of these closely spaced electrodes with the cardiac tissue provides the enhanced sensitivity of the lead to near field atrial signals.
  • a lead having this or a corresponding structure within the scope of the invention could be utilized in other areas of the body to achieve an enhanced sensitivity to local electrical signals and a reduced sensitivity to far field electrical signals from other areas of the body or external to the body.
  • the electrode assembly of Fig. 4 utilizes the helical anchor 25 to firmly hold the electrodes 17 and 19 in conductive contact with cardiac tissue.
  • the helical anchor ensures that the electrode 19 will not become dislodged from the tissue and thus reduce the sensitivity of the lead to atrial signals.
  • the helical anchor 25 is insulated from the electrodes 17 and 19 so that the tissue traumatized by entry of the anchor is not paced or sensed.
  • Fig. 5 illustrates an end elevation of the distal head portion of the pacing lead of Fig. 4, as viewed in the direction of the arrows 5-5.
  • Fig. 5 is provided to illustrate the coaxial relationship of the head of the electrode 17, ball 21 of the inner electrode 19 and insulated coils of the anchor 25.
  • Fig. 6 is a cross-sectional view of the distal end portion of an alternative embodiment of the pacing lead of the invention.
  • the tip electrode 17 is conductively connected to its associated outer coil 11 by a conducting sleeve 45 which may be made of a relatively rigid material, for example titanium or stainless steel.
  • the sleeve 45 is crimped inwardly so that it presses the coil 11 in firm conductive connection with a shank portion of the tip electrode 17.
  • An inner conducting electrode sleeve 47 is disposed within the tip electrode 17 in coaxial relation with the electrode.
  • the electrode sleeve 47 may be made of any suitable electrically conducting and biocompatible material, for example platinum, titanium or a platinum-iridium alloy such as is known in the art.
  • the sleeve 47 is held in insulated relation with respect to the tip electrode 17 by the insulating sleeve 15 which separates the coils 11 and 13.
  • the inner coil 13 is conductively connected to the inner electrode sleeve 47 by a crimping interaction between the sleeve 47 and an associated stake 49 which may be made of a relatively rigid material, for example titanium or stainless steel.
  • a post 50 of the stake 49 is disposed within the inner coil 13 and the electrode sleeve 47 is crimped to provide a firm conductive connection between the coil 13 and the sleeve.
  • the insulated corkscrew anchor 25 is disposed within an annular chamber defined between the wall of the electrode sleeve 47 and a post 51 of the stake 49.
  • the anchor 25 is affixed within the end of the sleeve 47 by crimping at crimp points 53 against the post 51.
  • Fig. 7 illustrates an end elevation of the distal electrode assembly of Fig. 6 as seen in the direction of the arrows 7-7.
  • the insulated corkscrew anchor 25 is potted within the electrode sleeve 47 by a medical adhesive such as Medical Adhesive Type A.
  • a medical adhesive such as Medical Adhesive Type A.
  • a polyurethane adhesive is used to affix and seal the tip electrode 17 to the polyurethane insulating sleeve 15 and the sleeve 15 to the inner electrode sleeve 47.
  • This adhesive is also used to glue and seal the outer insulating sheath 9 to the outer surface of the conducting sleeve 45 and a portion of the outer surface of the tip electrode 17.
  • the insulating sheaths are made of silicone rubber, another adhesive such as Medical Adhesive Type A is used.
  • the pacing lead of Fig. 6 operates in the same manner as the lead described with respect to Figs. 1-5.
  • the protruding end peripheral surface of the sleeve 47 is the inner electrode and the tip electrode 17 is the outer electrode of the bipolar lead.
  • an enhanced sensitivity to atrial P-waves results when these closely spaced electrodes are held in contact with atrial cardiac tissue 43 by the insulated corkscrew anchor 25.
  • Fig. 8 illustrates the distal end portion of another embodiment of the pacing lead of the invention.
  • the pacing lead has split electrically conducting electrodes 55 and 57 which may be made of any known biocompatible electrode material, such as a platinum-iridium alloy or titanium.
  • the electrodes 55 and 57 may be constructed with a solid titanium shank and an associated carbon coated porous tip made from sintered grains of titanium.
  • Fig. 9 illustrates the front end portions of the split electrodes 55 and 57 as seen in the direction of the arrows 9-9 of Fig. 8. It can be seen with reference to Figs. 8 and 9 that the split electrodes 55 and 57 are supported in insulated relation by an insulating pad 59 which may be made, for example of silicone rubber or polyurethane and which is affixed in sealed relation to the electrodes 55 and 57 by any known medical adhesive such as is previously discussed.
  • an insulating pad 59 which may be made, for example of silicone rubber or polyurethane and which is affixed in sealed relation to the electrodes 55 and 57 by any known medical adhesive such as is previously discussed.
  • the ends of the electrically conducting coils 11 and 13 are inserted into holes drilled in the shanks of the split electrodes 55 and 57, respectively.
  • the wires 11 and 13 are held in conductive connection with the split electrodes 55 and 57 by a medical adhesive or possibly by a biocompatible solder material.
  • the distal end of the lead has a tine assembly 61 which may be made of a relatively flexible, biocompatible material such as silicone rubber.
  • the assembly 61 is glued to the outer sheath 9 of the lead by any suitable known biocompatible medical adhesive.
  • tines 63 hold the electrodes 55 and 57 against cardiac tissue 43 by intermeshing with adjacent tissue of the heart.
  • the electrode of Fig. 8 senses atrial signals of the tissue 43 between the closely spaced split electrodes 55 and 57.
  • Fig. 10 illustrates a cross-sectional view of the distal end portion of another embodiment of the pacing lead of the invention.
  • the lead of Fig. 10 has three electrodes at its distal end. The first of these electrodes 17 is employed to pace the cardiac tissue 43 with respect to a ground provided by either the conducting housing of the pacer 1 or either or both of associated sensing electrodes 65 and 67.
  • the sensing electrodes 65 and 67 are respectively conductively connected by crimp sleeves 69 and 71 to associated electrically conducting coils 73 and 75.
  • the coils 73 and 75 are separated by an insulating sleeve 77 which may be made of polyurethane or silicone rubber.
  • the tip electrode 17 is conductively connected to an inner coil 79 by crimping a sleeve portion 81 of the electrode 17 against the coil 79 and an associated stake 83 which may be made of a relatively rigid material, such as titanium or stainless steel.
  • the lead of Fig. 10 also includes a tine assembly 61 which is affixed to the outer sheath 9 of the lead body by medical adhesive.
  • the sensing electrodes 65 and 67 are constructed in the manner generally described for the electrode 19 of Fig. 4. Each of the electrodes 65 and 67 are held in insulated relation with respect to the tip electrode 17 by insulating sleeves 85 and 87 which may be made of, for example silicone rubber. Alternatively, the electrodes may be potted within the electrode 17 by a suitable insulating medical adhesive such as Medical Adhesive Type A.
  • Fig. 11 shows an end elevation of the tip of the electrode of Fig. 10 as viewed in the direction of the arrows 11-11.
  • the electrodes 67 and 65 and the tip electrode 17 abut cardiac tissue 43 to stimulate and sense the tissue.
  • the electrode 17 is employed to stimulate the cardiac tissue 43 and the electrodes 65 and 67 are employed to detect electrical signals of the tissue.
  • the three-wire system of the lead of Fig. 10 is thus used to stimulate the heart with the large electrode 17 and to sense atrial signals with enhanced sensitivity between the electrodes 67 and 65.
  • Fig. 12 illustrates an alternative embodiment of the pacing lead of the invention which employs an electrically conducting tine assembly 89 as an electrode of the pacing lead.
  • the tine assembly 89 is mounted in insulated relation with the tip electrode 17 by an insulating sleeve 91 which may be made of, for example polyurethane or silicone rubber.
  • the tip electrode 17 is crimped to the inner conducting coil 13 against a titanium or stainless steel stake 88 in the manner previously described.
  • the conducting tine assembly 89 is conductively connected to the outer coil 11 by an electrically conductive crimped sleeve 93, made of for example titanium or stainless steel.
  • the tine assembly 89 may be made of a biocompatible metal, for example titanium or a conducting elastomer, for example silicone rubber impregnated with carbon. It is theorized that the projecting tines of the conducting tine assembly 89 will engage cardiac tissue adjacent to the tissue contacted by the electrode 17 and will therefore be sufficiently close to the electrode 17 to provide enhanced detection of atrial cardiac signals.
  • Fig. 13 illustrates a cross-sectional view of the distal end portion of another alternative embodiment of the lead of the invention.
  • intermeshed conductive coils 95 and 97 are used for the body of the lead.
  • the coils are independently insulated so that they do not short against one another within the lead.
  • a first coil 95 made of, for example, a nickel-cobalt alloy is intermeshed with a second metal coil 97 of the same material.
  • Each of the coils is covered with an insulating layer which is preferably an extruded coating of polyurethane.
  • the coil 95 is conductively connected to the shank of the tip electrode 17 by crimping the coil against a stake 4 made of titanium or stainless steel.
  • the crimps 39 cut through the insulation of the coil to provide a good electrical connection between the coil and the electrode 17.
  • the coil 97 is conductively connected to the inner electrode 19 of the lead by removing the insulation from the end of the coil and crimping this end to the end of the inner electrode in the manner described for the embodiment of Figs. 1-5.
  • the advantage of the electrode of Fig. 13 is that the intermeshed bifilar coils provide a flexible lead body which has a relatively small diameter.
  • sensing electrodes any desired number of sensing electrodes may be used, so long as at least two of the electrodes contact tissue, for example atrial tissue, to detect near field signals.
  • sensing electrodes may be placed on different lead bodies or on different portions of a single lead body, so long as at least two sensing electrodes simultaneously contact tissue in a desired area to detect near field signals.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Claims (11)

1. Conducteur pour stimulateur cardiaque présentant une extrémité du stimulateur pour liaison conductrice avec un stimulateur cardiaque, une extrémité distante du stimulateur avec des électrodes pour contact conducteur avec le tissu cardiaque ainsi que des moyens conducteurs pour relier en conduction les électrodes de l'extrémité distante avec l'extrémité proche, caractérisé par:
au moins deux électrodes disposées à ladite extrémité distante et présentant des surfaces de contact pour contacter simultanément, avec conduction, une zone sélectionnée du tissu cardiaque et transmettre audit stimulateur cardiaque par lesdits moyens conducteurs, les signaux cardiaques détectés entre les électrodes; et
des moyens prévus pour supporter lesdites électrodes, dont il y a au moins deux, isolées l'une de l'autre, lesdites surfaces de contact se trouvant sensiblement dans le même plan l'une que l'autre pour rendre maximale l'amplitude détectée des signaux cardiaques apparaissant à une certaine distance desdites électrodes.
2. Conducteur pour stimulateur cardiaque selon la revendication 1, dans lequel ladite zone sélectionnée de tissu cardiaque est une zone de l'orifice de l'oreillette d'un coeur et dans lequel lesdits moyens prévus pour supporter comprennent des moyens pour définir un écartement des électrodes pour lequel le rapport entre l'amplitude détectée des signaux provenant de l'orifice de l'oreillette et l'amplitude détectée des signaux ventriculaires est rendu maximal pour faciliter la détection desdits signaux provenant de l'orifice de l'oreillette.
3. Conducteur de stimulateur cardiaque selon la revendication 1 ou 2, dans lequel l'une desdites électrodes est constituée d'un fil-électrode conducteur avec une bille conductrice à son extrémité libre et dans lequel l'autre desdites électrodes est une douille-électrode conductrice, lesdits moyens prévus pour supporter comprenant des moyens isolants pour maintenir ledit fil-électrode coaxial et isolé à l'intérieur de ladite douille-électrode, de sorte que la bille et la douille s'étendent pour contacter simultanément en conduction ladite zone sélectionnée du tissu cardiaque.
4. Conducteur pour stimulateur cardiaque selon la revendication 1, 2 ou 3, comportant en outre un ancrage hélicoïdal pour maintenir lesdites électrodes en contact conducteur avec ledit tissu cardiaque.
5. Conducteur de stimulateur cardiaque selon la revendication 4, comportant des moyens pour isoler ledit ancrage hélicoïdal d'avec lesdites électrodes.
6. Conducteur pour stimulateur cardiaque selon l'une quelconque des revendications précédentes, dans lequel lesdits moyens prévus pour supporter sont disposés pour supporter lesdites électrodes à un écartement sélectionné d'au maximum un millimètre.
7. Conducteur pour stimulateur cardiaque selon l'une quelconque des revendications précédentes, dans lequel l'une desdites électrodes est un douille extérieure conductrice présentant une surface de contact avant dans un plan de contact et dans lequel l'autre desdites électrodes est une douille intérieure conductrice placée à l'intérieur de ladite douille extérieure et présentant une surface de contact avant située dans ledit plan et disposée radialement à l'intérieur de la surface de contact avant de la douille extérieure.
8. Conducteur pour stimulateur cardiaque selon l'une quelconque des revendications précédentes, dans lequel l'une desdites électrodes forme une plaquette conductrice définissant une première surface de contact dans un plan de contact et l'autre desdites électrodes forme une autre plaquette conductrice définissant une seconde surface de contact dans ledit plan.
9. Conducteur pour stimulateur cardiaque selon la revendication 1, dans lequel chacune desdites électrodes est constituée d'un fil-électrode conducteur avec une bille conductrice à son extrémité libre.
10. Conducteur pour stimulateur cardiaque selon la revendication 1, dans lequel l'une desdites électrodes forme une plaquette conductrice disposée dans un plan de contact avant et dans lequel l'autre desdites électrodes est un moyen conducteur de fixation présentant des fourchons conducteurs pour maintenir ladite plaquette conductrice contre le tissu cardiaque et pour contacter en conduction le tissu cardiaque adjacent.
11. Conducteur pour stimulateur cardiaque selon la revendication 1, dans lequel lesdits moyens conducteurs comportent au moins deux bobines conductrices, isolées, se vissant l'une dans l'autre.
EP85309233A 1985-01-16 1985-12-18 Conducteur pour stimulateur cardiaque à sensibilité élevée Expired - Lifetime EP0191238B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT85309233T ATE53502T1 (de) 1985-01-16 1985-12-18 Herzschrittmacher-elektrodenleitung mit erhoehter empfindlichkeit.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US692352 1985-01-16
US06/692,352 US4662382A (en) 1985-01-16 1985-01-16 Pacemaker lead with enhanced sensitivity

Publications (2)

Publication Number Publication Date
EP0191238A1 EP0191238A1 (fr) 1986-08-20
EP0191238B1 true EP0191238B1 (fr) 1990-06-13

Family

ID=24780233

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85309233A Expired - Lifetime EP0191238B1 (fr) 1985-01-16 1985-12-18 Conducteur pour stimulateur cardiaque à sensibilité élevée

Country Status (6)

Country Link
US (1) US4662382A (fr)
EP (1) EP0191238B1 (fr)
JP (1) JPS61164566A (fr)
AT (1) ATE53502T1 (fr)
CA (1) CA1265585A (fr)
DE (1) DE3578130D1 (fr)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4640706A (en) * 1984-03-30 1987-02-03 Ciba-Geigy Corporation Cyclohexenonecarboxylic acid derivatives with herbicidal and plant growth regulating properties
US4791911A (en) * 1986-06-02 1988-12-20 Allegheny-Singer Research Institute Method of cardiac reconstructive surgery
US4796643A (en) * 1986-09-30 1989-01-10 Telectronics N.V. Medical electrode leads
US4784161A (en) * 1986-11-24 1988-11-15 Telectronics, N.V. Porous pacemaker electrode tip using a porous substrate
FR2616072B1 (fr) * 1987-06-04 1990-12-14 Ela Medical Sa Perfectionnements aux extremites conductrices de sondes de stimulation cardiaque
USD328495S (en) 1990-04-02 1992-08-04 Advanced Technology Laboratories, Inc. Ultrasonic transducer probe
US5366493A (en) * 1991-02-04 1994-11-22 Case Western Reserve University Double helix functional stimulation electrode
US5179962A (en) * 1991-06-20 1993-01-19 Possis Medical, Inc. Cardiac lead with retractible fixators
IT1253047B (it) * 1991-10-02 1995-07-10 Xtrode Srl Elettrodo ad ancoraggio attivo per elettrocateteri
EP0571797B2 (fr) * 1992-05-25 2005-10-26 St. Jude Medical AB Appareil de stimulation cardiaque
EP0585553B1 (fr) * 1992-08-14 1999-09-15 Pacesetter AB Fil d'électrode multipolaire
US5385578A (en) * 1993-02-18 1995-01-31 Ventritex, Inc. Electrical connection for medical electrical stimulation electrodes
US5488768A (en) * 1993-09-24 1996-02-06 Ventritex, Inc. Method of forming a defibrillation electrode connection
US5380320A (en) * 1993-11-08 1995-01-10 Advanced Surgical Materials, Inc. Electrosurgical instrument having a parylene coating
DE4440386A1 (de) * 1994-11-11 1996-05-15 Pacesetter Ab Elektroden für medizinische Anwendungen
US5522872A (en) * 1994-12-07 1996-06-04 Ventritex, Inc. Electrode-conductor sleeve joint for cardiac lead
US5654030A (en) * 1995-02-07 1997-08-05 Intermedics, Inc. Method of making implantable stimulation electrodes
US5683443A (en) * 1995-02-07 1997-11-04 Intermedics, Inc. Implantable stimulation electrodes with non-native metal oxide coating mixtures
FR2751232B1 (fr) * 1996-07-19 1998-09-25 Ela Medical Sa Sonde pour dispositif medical implante, notamment pour stimulateur cardiaque
US5796044A (en) * 1997-02-10 1998-08-18 Medtronic, Inc. Coiled wire conductor insulation for biomedical lead
US6501994B1 (en) * 1997-12-24 2002-12-31 Cardiac Pacemakers, Inc. High impedance electrode tip
US6152954A (en) 1998-07-22 2000-11-28 Cardiac Pacemakers, Inc. Single pass lead having retractable, actively attached electrode for pacing and sensing
US6212434B1 (en) 1998-07-22 2001-04-03 Cardiac Pacemakers, Inc. Single pass lead system
US5897585A (en) * 1997-12-18 1999-04-27 Medtronic, Inc. Stretchable pacing lead
US6047217A (en) * 1998-01-15 2000-04-04 Intermedics Inc. Cardiac lead with improved polymer-to-metal joint
US6556862B2 (en) * 1998-03-19 2003-04-29 Cardiac Pacemakers, Inc. Method and apparatus for treating supraventricular tachyarrhythmias
US6246906B1 (en) 1998-03-19 2001-06-12 Cardiac Pacemakers, Inc. System and method for treating atrial arrhythmias
US6256541B1 (en) 1998-04-17 2001-07-03 Cardiac Pacemakers, Inc. Endocardial lead having defibrillation and sensing electrodes with septal anchoring
US6240320B1 (en) 1998-06-05 2001-05-29 Intermedics Inc. Cardiac lead with zone insulated electrodes
US6134478A (en) * 1998-06-05 2000-10-17 Intermedics Inc. Method for making cardiac leads with zone insulated electrodes
US6501990B1 (en) 1999-12-23 2002-12-31 Cardiac Pacemakers, Inc. Extendable and retractable lead having a snap-fit terminal connector
US6463334B1 (en) 1998-11-02 2002-10-08 Cardiac Pacemakers, Inc. Extendable and retractable lead
DE69921447T2 (de) 1999-04-02 2005-11-24 Sorin Biomedica Crm S.R.L., Saluggia Ankerstruktur für implantierbare Elektroden
WO2001002053A1 (fr) * 1999-07-07 2001-01-11 Cardiac Pacemakers, Inc. Ensemble electrode endocavitaire presentant des caracteristiques de fixation conductrices
US6408213B1 (en) * 1999-09-29 2002-06-18 Cardiac Pacemakers, Inc. Low profile, ventricular, transvenous, epicardial defibrillation lead
US6847842B1 (en) 2000-05-15 2005-01-25 Cardiac Pacemakers, Inc. Method and apparatus for reducing early recurrence of atrial fibrillation with defibrillation shock therapy
US6574512B1 (en) 2000-08-28 2003-06-03 Cardiac Pacemakers, Inc. Lead system with main lead and transverse lead
US6684109B1 (en) * 2000-09-13 2004-01-27 Oscor Inc. Endocardial lead
US6978185B2 (en) * 2001-11-09 2005-12-20 Oscor Inc. Multifilar conductor for cardiac leads
US7142928B2 (en) * 2001-12-03 2006-11-28 Medtronic, Inc. Field stimulation about a discontinuity of the myocardium to capture the heart at reduced pacing thresholds
US20040092806A1 (en) * 2001-12-11 2004-05-13 Sagon Stephen W Microelectrode catheter for mapping and ablation
US6978178B2 (en) * 2002-04-30 2005-12-20 Medtronic, Inc. Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode array
EP2075014B9 (fr) 2002-05-24 2012-02-01 Angiotech International Ag Compositions et procédés pour le revêtement d'implants médicaux
US7684861B2 (en) * 2003-11-13 2010-03-23 Cardiac Pacemakers, Inc. Implantable cardiac monitor upgradeable to pacemaker or cardiac resynchronization device
US7299086B2 (en) * 2004-03-05 2007-11-20 Cardiac Pacemakers, Inc. Wireless ECG in implantable devices
US7720550B2 (en) * 2004-12-03 2010-05-18 Medtronic, Inc. High impedance active fixation electrode of an electrical medical lead
US8005544B2 (en) 2004-12-20 2011-08-23 Cardiac Pacemakers, Inc. Endocardial pacing devices and methods useful for resynchronization and defibrillation
US8010191B2 (en) 2004-12-20 2011-08-30 Cardiac Pacemakers, Inc. Systems, devices and methods for monitoring efficiency of pacing
US8423139B2 (en) * 2004-12-20 2013-04-16 Cardiac Pacemakers, Inc. Methods, devices and systems for cardiac rhythm management using an electrode arrangement
US8290586B2 (en) 2004-12-20 2012-10-16 Cardiac Pacemakers, Inc. Methods, devices and systems for single-chamber pacing using a dual-chamber pacing device
US9006487B2 (en) * 2005-06-15 2015-04-14 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
EP1968690A4 (fr) * 2005-12-22 2009-02-18 Mayo Foundation Electrodes helicoidales pour une stimulation electrique et une détection intramyocardiques
US8126529B2 (en) 2006-09-22 2012-02-28 Advanced Neuromodulation Systems, Inc. Methods and systems for securing electrode leads
US20080294229A1 (en) * 2006-10-17 2008-11-27 Friedman Paul A Helical Electrodes for Intramyocardial Pacing and Sensing
US7822484B1 (en) * 2007-04-03 2010-10-26 Pacesetter, Inc. MRI-compatible implantable lead having high impedance electrodes
US20090054947A1 (en) * 2007-08-20 2009-02-26 Medtronic, Inc. Electrode configurations for directional leads
EP2195078B1 (fr) 2007-08-20 2013-10-09 Medtronic, Inc. Conducteur médical implantable avec électrode polarisée
US8326418B2 (en) 2007-08-20 2012-12-04 Medtronic, Inc. Evaluating therapeutic stimulation electrode configurations based on physiological responses
ES2646630T3 (es) 2008-11-07 2017-12-14 Massachusetts Institute Of Technology Lipidoides aminoalcohólicos y usos de los mismos
US8364281B2 (en) * 2008-11-07 2013-01-29 W. L. Gore & Associates, Inc. Implantable lead
US8996134B2 (en) 2008-11-07 2015-03-31 W. L. Gore & Associates, Inc. Implantable lead
EP2473228B1 (fr) 2009-09-03 2014-12-31 Mayo Foundation For Medical Education And Research Câbles de stimulation, de détection ou de défibrillateur pour implantation dans le myocarde
HUE042177T2 (hu) 2009-12-01 2019-06-28 Translate Bio Inc Szteroidszármazék mRNS szállítására humán genetikai betegségekben
EP2609135A4 (fr) 2010-08-26 2015-05-20 Massachusetts Inst Technology Poly(bêta-amino-alcools), leur préparation et utilisations de ceux-ci
US9238716B2 (en) 2011-03-28 2016-01-19 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
PL3586861T3 (pl) 2011-06-08 2022-05-23 Translate Bio, Inc. Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna
EP3536787A1 (fr) 2012-06-08 2019-09-11 Translate Bio, Inc. Polynucléotides résistant aux nucléases et leurs utilisations
PL3467108T3 (pl) 2013-03-14 2024-09-30 Translate Bio, Inc. Sposoby oczyszczania informacyjnego rna
KR20210122917A (ko) 2013-03-14 2021-10-12 샤이어 휴먼 지네틱 테라피즈 인크. Cftr mrna 조성물 및 관련 방법 및 사용
CN105164920B (zh) 2013-03-15 2018-02-06 艾尔弗雷德·E·曼科学研究基金会 具有快速开启时间的电流感测多输出电流刺激器
WO2014179562A1 (fr) 2013-05-01 2014-11-06 Massachusetts Institute Of Technology Dérivés de 1,3,5-triazinane-2,4,6-trione et leurs utilisations
US9780596B2 (en) 2013-07-29 2017-10-03 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
US10071243B2 (en) 2013-07-31 2018-09-11 Medtronic, Inc. Fixation for implantable medical devices
US9393427B2 (en) 2013-08-16 2016-07-19 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with delivery and/or retrieval features
CN105916544B (zh) 2013-08-16 2019-11-12 心脏起搏器股份公司 无引线心脏起搏设备
US9480850B2 (en) 2013-08-16 2016-11-01 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker and retrieval device
EP3033146B1 (fr) 2013-08-16 2018-03-07 Cardiac Pacemakers, Inc. Dispositif d'administration destinés à des dispositifs cardiaques sans conducteur
WO2015023474A1 (fr) 2013-08-16 2015-02-19 Cardiac Pacemakers, Inc. Stimulateur cardiaque sans fil et dispositif de récupération
US9492674B2 (en) 2013-08-16 2016-11-15 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with delivery and/or retrieval features
US10722723B2 (en) 2013-08-16 2020-07-28 Cardiac Pacemakers, Inc. Delivery devices and methods for leadless cardiac devices
US10842993B2 (en) 2013-08-16 2020-11-24 Cardiac Pacemakers, Inc. Leadless cardiac pacing devices
EA034103B1 (ru) 2013-10-22 2019-12-27 Транслейт Био, Инк. СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
ES2707966T3 (es) 2013-10-22 2019-04-08 Translate Bio Inc Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
MX2016005238A (es) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Formulaciones de lipidos para la administracion de acido ribonucleico mensajero.
PT3134506T (pt) 2014-04-25 2019-10-31 Translate Bio Inc Métodos de purificação de rna mensageiro
WO2015168155A1 (fr) 2014-04-29 2015-11-05 Cardiac Pacemakers, Inc. Stimulateur cardiaque sans fil à caractéristiques permettant son extraction
US10080887B2 (en) 2014-04-29 2018-09-25 Cardiac Pacemakers, Inc. Leadless cardiac pacing devices including tissue engagement verification
JP6557722B2 (ja) 2014-05-30 2019-08-07 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための生分解性脂質
EP3160959B1 (fr) 2014-06-24 2023-08-30 Translate Bio, Inc. Compositions enrichies stéréochimiquement pour l'administration d'acides nucléiques
US9840479B2 (en) 2014-07-02 2017-12-12 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
CN106999709B (zh) 2014-08-15 2021-07-09 艾克索尼克斯股份有限公司 用于与可植入神经刺激器一起使用的集成肌电图临床医生程控器
AU2015301489B2 (en) 2014-08-15 2020-01-23 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
CN107073258B (zh) 2014-08-15 2020-02-21 艾克索尼克斯调制技术股份有限公司 用于基于神经定位来进行神经刺激电极配置的系统和方法
US9802038B2 (en) 2014-08-15 2017-10-31 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
US9700731B2 (en) 2014-08-15 2017-07-11 Axonics Modulation Technologies, Inc. Antenna and methods of use for an implantable nerve stimulator
WO2016025913A1 (fr) 2014-08-15 2016-02-18 Axonics Modulation Technologies, Inc. Positionnement d'une dérivation électromyographique et titrage de la stimulation dans un système de stimulation nerveuse pour le traitement de la vessie hyperactive
CN107427685B (zh) 2015-01-09 2021-09-21 艾克索尼克斯股份有限公司 与神经刺激充电设备一起使用的附接设备及相关联方法
WO2016112398A1 (fr) 2015-01-09 2016-07-14 Axonics Modulation Technologies, Inc. Patient distant et procédés associés d'utilisation avec un système de stimulation nerveuse
AU2016291554B2 (en) 2015-07-10 2021-01-07 Axonics Modulation Technologies, Inc. Implantable nerve stimulator having internal electronics without ASIC and methods of use
US10099050B2 (en) 2016-01-21 2018-10-16 Medtronic, Inc. Interventional medical devices, device systems, and fixation components thereof
US10463853B2 (en) 2016-01-21 2019-11-05 Medtronic, Inc. Interventional medical systems
WO2017132374A1 (fr) 2016-01-29 2017-08-03 Axonics Modulation Technologies, Inc. Procédés et systèmes pour ajustement de fréquence pour optimiser la charge d'un neurostimulateur implantable
AU2017218157B2 (en) 2016-02-12 2022-09-29 Axonics, Inc. External pulse generator device and associated methods for trial nerve stimulation
EA201991747A1 (ru) 2017-02-27 2020-06-04 Транслейт Био, Инк. НОВАЯ КОДОН-ОПТИМИЗИРОВАННАЯ мРНК CFTR
MX2019013752A (es) 2017-05-16 2020-07-20 Translate Bio Inc Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones.
JP7677791B2 (ja) 2018-02-22 2025-05-15 アクソニクス インコーポレイテッド 試験的神経刺激のための神経刺激リードおよび使用方法
CA3108544A1 (fr) 2018-08-24 2020-02-27 Translate Bio, Inc. Procedes de purification d'arn messager
MX2021005969A (es) 2018-11-21 2021-09-14 Translate Bio Inc Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.
US11642537B2 (en) 2019-03-11 2023-05-09 Axonics, Inc. Charging device with off-center coil
US11759632B2 (en) 2019-03-28 2023-09-19 Medtronic, Inc. Fixation components for implantable medical devices
WO2020242900A1 (fr) 2019-05-24 2020-12-03 Axonics Modulation Technologies, Inc. Dispositif d'entraînement pour un programmateur de neurostimulateur et procédés associés d'utilisation avec un système de neurostimulation
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures
US12420103B1 (en) 2020-08-20 2025-09-23 Axonics, Inc. Neurostimulation leads with reduced current leakage

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3757789A (en) * 1971-10-26 1973-09-11 I Shanker Electromedical stimulator lead connector
US4010755A (en) * 1972-11-28 1977-03-08 Preston Thomas A Unipolar pacing catheter with plural distal electrodes
US4033357A (en) * 1975-02-07 1977-07-05 Medtronic, Inc. Non-fibrosing cardiac electrode
DE2516848A1 (de) * 1975-04-17 1976-10-28 Silvester Sztasko Transvenoese stimulationselektrode fuer herzschrittmacher
DE2952818A1 (de) * 1979-12-28 1981-07-02 Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin Elektrode fuer einen implantierbaren herzschrittmacher
US4365639A (en) * 1980-02-07 1982-12-28 Applied Cardiac Electrophysiology Catheter, cardiac pacemaker and method of pacing
DE3025955A1 (de) * 1980-07-09 1982-01-21 Forschungsgesellschaft für Biomedizinische Technik, 5100 Aachen Ableitelektrode zur aufnahme bioelektrischer aktivitaet von behaarten koerperregionen
FR2490079A1 (fr) * 1980-09-15 1982-03-19 Boussac Saint Freres Bsf Procede de fabrication de couches-culottes a jeter et couches-culottes obtenues par la mise en oeuvre de ce procede
DE3046667A1 (de) * 1980-12-11 1982-07-22 Peter Dr. 7850 Lörrach Osypka Herzschrittmacher-elektrode
US4402328A (en) * 1981-04-28 1983-09-06 Telectronics Pty. Limited Crista terminalis atrial electrode lead
US4444195A (en) * 1981-11-02 1984-04-24 Cordis Corporation Cardiac lead having multiple ring electrodes
DE3230081A1 (de) * 1982-08-13 1984-02-16 Stöckert-Instrumente Apparatebau GmbH & Co Fertigungs- u. Vertriebs KG, 8000 München Transvenoese, implantierbare herzschrittmacherelektrode
US4463765A (en) * 1982-08-30 1984-08-07 Cordis Corporation Screw-in pacing lead assembly
US4502492A (en) * 1983-04-28 1985-03-05 Medtronic, Inc. Low-polarization low-threshold electrode

Also Published As

Publication number Publication date
DE3578130D1 (de) 1990-07-19
ATE53502T1 (de) 1990-06-15
US4662382A (en) 1987-05-05
JPS61164566A (ja) 1986-07-25
CA1265585A (fr) 1990-02-06
EP0191238A1 (fr) 1986-08-20

Similar Documents

Publication Publication Date Title
EP0191238B1 (fr) Conducteur pour stimulateur cardiaque à sensibilité élevée
US4892102A (en) Cardiac pacing and/or sensing lead and method of use
US6104961A (en) Endocardial defibrillation lead with looped cable conductor
US6249709B1 (en) Endocardial defibrillation lead with multi-lumen body and axially mounted distal electrode
US6259954B1 (en) Endocardial difibrillation lead with strain-relief coil connection
US4585004A (en) Heart pacing and intracardiac electrogram monitoring system and associated method
US5545201A (en) Bipolar active fixation lead for sensing and pacing the heart
US7027852B2 (en) Lead with distal tip surface electrodes connected in parallel
EP0596319B1 (fr) Appareil de stimulation cardiaque
US4387717A (en) Pacer internal cardiac electrogram sensing system
US6980866B2 (en) Apparatus for sensing cardiac contractile function
US3788329A (en) Body implantable lead
US5324326A (en) Pressure sensing pacing lead
US7383091B1 (en) Medical electrical lead providing far-field signal attenuation
US5423883A (en) Implantable myocardial stimulation lead with sensors thereon
US4532931A (en) Pacemaker with adaptive sensing means for use with unipolar or bipolar leads
US6097986A (en) Retractable lead with mesh screen
US20050043770A1 (en) Multi-polar electrical medical lead connector system
US5968086A (en) Pacing and cardioversion lead systems with shared lead conductors
US20080004535A1 (en) Implantable medical device with sensing electrodes
US5948014A (en) Implantable stimulation system having a single-pass, tripolar lead and programmable polarity
US7305270B1 (en) Cardiac pacing/sensing lead providing far-field signal rejection
US20040106964A1 (en) Implantable Medical Device with Multiple Electrode Lead and Connector with Central Fastener
EP0159753A1 (fr) Conducteur cardiaque
US8521286B2 (en) Lead-carried proximal electrode for quadripolar transthoracic impedance monitoring

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19861010

17Q First examination report despatched

Effective date: 19880202

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19900613

Ref country code: NL

Effective date: 19900613

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 19900613

Ref country code: BE

Effective date: 19900613

Ref country code: AT

Effective date: 19900613

REF Corresponds to:

Ref document number: 53502

Country of ref document: AT

Date of ref document: 19900615

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3578130

Country of ref document: DE

Date of ref document: 19900719

ET Fr: translation filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19901120

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19901121

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19901128

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19901231

EPTA Lu: last paid annual fee
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19911231

Ref country code: CH

Effective date: 19911231

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

ITTA It: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20001130

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20001201

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20001211

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20011218

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020702

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20011218

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020830

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST